225Ac-labeled ( S )-ibuprofen-diaminobutyric acid-PSMA (SibuDAB) is a novel, albumin-binding compound in prostate-specific membrane antigen (PSMA)–targeted α-therapy of prostate cancer. It showed ...

252225 Introduction: Immunotherapy (IMT) is a promising treatment for various cancers however, the accurate early identification of responders remains a significant challenge. Positron emission ...

25124 Introduction: Quality assessment and protocol optimization are standard practices at our institution. Collaboration with medical physicists and physicians is critical in enhancing imaging ...

252093 Introduction: FDG PET imaging with myocardial glucose suppression is the clinical standard for diagnosing cardiac sarcoidosis. Precise myocardial segmentation is essential for accurate image ...

251879 Introduction: To obtain radiomics features from Amyloid PET scans and explore their relationship with clinical indicators, including the Montreal Cognitive Assessment (MoCA), Clinical Dementia ...

Results: The integration of 11C-PiB PET/CT and 99mTc-DPD scintigraphy substantially enhanced diagnostic performance. 11C-PiB PET/CT demonstrated high sensitivity for AL amyloidosis, achieving an AUC ...

251450 Introduction: Cardiac sarcoidosis (CS) diagnosis poses significant challenges due to its varied clinical presentations and the absence of a definitive diagnostic gold standard. This ongoing ...

251500 Introduction: Temporal lobe epilepsy (TLE) patients often experience exacerbation of seizures following COVID-19 infection, a condition referred to as post-COVID-19 active TLE. Although ...

251219 Introduction: Our aimed to discover new marker by analysing the proteomics of PSMA-negative PCa tissue and develope targeted radiolabeled probe to assess its potential for PCa theranostics.

251692 Introduction: Clinical PET/CT scanners are often saturated because of the high demand for oncological studies. Brain-dedicated PET systems would allow greater accessibility for PET studies in ...

251354 Introduction: Targeted radiotherapies (TR) are emerging as a powerful treatment for cancer patients that have failed conventional therapies. Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) ...

25138 Introduction: Introduction: Radiopharmaceutical therapies (RPT) represent transformative advances in personalized cancer care. These treatments demand a structured workflow to ensure safety, ...